B

Breye Therapeutics

HealthRetinal DiseasesB2C📍 Denmark

Breye Therapeutics is developing oral therapies for the early treatment of retinal diseases. This funding will advance their pipeline of novel treatments. The company aims to provide more accessible and convenient options for patients suffering from conditions like age-related macular degeneration and diabetic retinopathy.

Total raised
Undisclosed
tracked to date
Latest round
€67.5 million
Oct 2, 2026

Is this your company?

Claim this profile to get matched with investors who fund Health startups in Denmark.

Claim this profile →

Funding history

  1. 1
    €67.5 millionOct 2, 2026
    Announcement ↗

Breye Therapeutics in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile